Hepatology
News
New insights into how omega-3 fatty acids improve NASH
BTC was consistently upregulated in liver cancer and downregulated by omega-3 polyunsaturated fatty acids in mice and humans with NASH.
Opinion
Diagnosing patients with sarcoidosis
Sarcoidosis should always be part of the differential when you see lymphopenia.
Conference Coverage
Weight-loss drugs improve liver measures, too
Body weight reduction of at least 3% within 8 weeks of beginning treatment with either an SLT-2 or GLP-1 agent was associated independently with...
News
MASLD, MASH projected to grow by 23% in the U.S. through 2050
“In the absence of effective treatments, health systems should plan for large increases in the number of liver cancer cases and the need for liver...
News
MASLD linked to increased risk for various clinical outcomes
The disease significantly raises the risk for cardiovascular, metabolic, oncologic, and other outcomes.
News
NAFLD raises risk for colorectal adenomatous polyps
In the fully adjusted model, NAFLD was a significant independent risk factor for adenomatous polyps but not for nonadenomatous polyps.
News
GLP-1 agonists offer multiple benefits in type 2 diabetes with liver cirrhosis
“GLP-1 RAs may be a treatment option for diabetes patients with liver cirrhosis,” but additional studies are needed to confirm the results, the...
Opinion
What’s new in the new jaundice guidelines?
The neurotoxic risk factors and corresponding thresholds are important.
News
SAFE algorithm detects liver disease in general population
Scoring system was developed and validated to detect clinically significant (greater than stage 2) fibrosis in patients with NAFLD in primary care...
News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.